Heterozygotes of NOS3 Polymorphisms Contribute to Reduced Nitrogen Oxides in High-Altitude Pulmonary Edema
High-altitude pulmonary edema (HAPE), which develops on exertion under hypoxic conditions, aggravates due to endothelial dysfunction. Repeat events of the disorder suggests of genetic susceptibility. Endothelial nitric oxide synthase gene (NOS3), a regulator of vasodilation, has emerged as a strong...
Gespeichert in:
Veröffentlicht in: | Chest 2006-11, Vol.130 (5), p.1511-1519 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1519 |
---|---|
container_issue | 5 |
container_start_page | 1511 |
container_title | Chest |
container_volume | 130 |
creator | Ahsan, Aarif Mohd, Ghulam Norboo, Tsering Baig, Masroor A. Pasha, M. A. Qadar |
description | High-altitude pulmonary edema (HAPE), which develops on exertion under hypoxic conditions, aggravates due to endothelial dysfunction. Repeat events of the disorder suggests of genetic susceptibility. Endothelial nitric oxide synthase gene (NOS3), a regulator of vasodilation, has emerged as a strong candidate marker. In the present study, we investigated G894T, 27-base-pair 4b/4a (variable number of tandem repeat), −922A/G, and −786T/C polymorphisms of NOS3, individually or in combination, for an association with HAPE.
A cross-sectional case control study.
Blood samples of HAPE-resistant lowlanders (HAPE-r) were obtained at sea level, and blood samples of patients with HAPE (HAPE-p) were obtained at Sonam Norboo Memorial Hospital, Leh, at 3,500 m.
The study groups consisted of 60 HAPE-r inducted two to three times to altitudes > 3,600 m; and 72 HAPE-p, who had HAPE on their first visit to high altitude.
Nitrogen oxides (NOx) at 77.9 ± 28.6 μmol/L were significantly elevated in HAPE-r as compared to 42.39 ± 12.93 μmol/L in HAPE-p (p < 0.0001). Genotype distribution of G894T and 4b/4a polymorphisms was significantly different in the two groups (p = 0.001 and 0.009, respectively). Haplotype analysis revealed −922A/G and −786T/C polymorphisms in complete linkage disequilibrium. The wild-type haplotypes G-b (G894T, 4b/4a), G-A (G894T, −922A/G), and G-b-A (G894T, 4b/4a, −922A/G) were significantly overrepresented in HAPE-r (p < 0.0001, p = 0.03, and p = 0.02, respectively). The heterozygote genotype combination GTba as compared to wild-type combination GGbb was significantly higher in HAPE-p (χ2 = 18.62, p = 0.00009; odds ratio, 7.20; 95% confidence interval, 2.82 to 18.38). The combination of four heterozygotes GTbaAGTC was overrepresented in HAPE-p (p = 0.04), whereas the wild-type genotype combination GGbbAATT was overrepresented in HAPE-r (p = 0.002). Furthermore, the GGbb combination correlated with significantly elevated NOx as compared to remaining combinations as a whole in both HAPE-r and HAPE-p (p = 0.01 and 0.004, respectively).
Reduced NOx and combination of heterozygotes associate with the susceptibility to HAPE. The study impels another step toward application of NOx as a diagnostic marker for HAPE. The NOS3 GTba and GTbaAGTC genotype combinations may find application as genetic markers for predicting the risk for HAPE. |
doi_str_mv | 10.1378/chest.130.5.1511 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68134321</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S001236921537330X</els_id><sourcerecordid>1174702201</sourcerecordid><originalsourceid>FETCH-LOGICAL-c512t-e705beb5255fdd2f41d6c7631b1fbc43c3b0994ba05402ee445c5b3e6db80cb83</originalsourceid><addsrcrecordid>eNp1kd1v0zAUxS0EYmXwzhOykMZbih3bacLbVG0UaVonPp6t2L5pXTlxsR1Y-evxaKSKSXuyLf3OvcfnIPSWkjlli_qj3kJM-UrmYk4Fpc_QjDaMFkxw9hzNCKFlwaqmPEOvYtyR_KZN9RKd0QVpGsLoDO1WkCD4P4eNTxCx7_Dt-hvDd94deh_2Wxv7iJd-SMGqMQFOHn8FM2ow-Nam4Dcw4PW9NVlrB7yym21x6ZJNowF8N7reD2044CsDffsavehaF-HNdJ6jH9dX35er4mb9-cvy8qbQgpapgAURCpQoheiMKTtOTaUXFaOKdkpzppnK5rlqieCkBOBcaKEYVEbVRKuanaMPx7n74H-OOSDZ26jBuXYAP0ZZ1ZRxVtIMvn8E7vwYhuxNloTwitd1kyFyhHTwMQbo5D7YPn9KUiIfSpD_SshXIoV8KCFL3k1zR9WDOQmm1DNwMQFt1K3rQjtoG09cXTZNzerT7m3O9bcNIGPfOpfHsuPWye9_uz8dJZAT_mUhyKgtDLmvLNdJGm-fNv4XjGu1_w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>200464889</pqid></control><display><type>article</type><title>Heterozygotes of NOS3 Polymorphisms Contribute to Reduced Nitrogen Oxides in High-Altitude Pulmonary Edema</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Ahsan, Aarif ; Mohd, Ghulam ; Norboo, Tsering ; Baig, Masroor A. ; Pasha, M. A. Qadar</creator><creatorcontrib>Ahsan, Aarif ; Mohd, Ghulam ; Norboo, Tsering ; Baig, Masroor A. ; Pasha, M. A. Qadar</creatorcontrib><description>High-altitude pulmonary edema (HAPE), which develops on exertion under hypoxic conditions, aggravates due to endothelial dysfunction. Repeat events of the disorder suggests of genetic susceptibility. Endothelial nitric oxide synthase gene (NOS3), a regulator of vasodilation, has emerged as a strong candidate marker. In the present study, we investigated G894T, 27-base-pair 4b/4a (variable number of tandem repeat), −922A/G, and −786T/C polymorphisms of NOS3, individually or in combination, for an association with HAPE.
A cross-sectional case control study.
Blood samples of HAPE-resistant lowlanders (HAPE-r) were obtained at sea level, and blood samples of patients with HAPE (HAPE-p) were obtained at Sonam Norboo Memorial Hospital, Leh, at 3,500 m.
The study groups consisted of 60 HAPE-r inducted two to three times to altitudes > 3,600 m; and 72 HAPE-p, who had HAPE on their first visit to high altitude.
Nitrogen oxides (NOx) at 77.9 ± 28.6 μmol/L were significantly elevated in HAPE-r as compared to 42.39 ± 12.93 μmol/L in HAPE-p (p < 0.0001). Genotype distribution of G894T and 4b/4a polymorphisms was significantly different in the two groups (p = 0.001 and 0.009, respectively). Haplotype analysis revealed −922A/G and −786T/C polymorphisms in complete linkage disequilibrium. The wild-type haplotypes G-b (G894T, 4b/4a), G-A (G894T, −922A/G), and G-b-A (G894T, 4b/4a, −922A/G) were significantly overrepresented in HAPE-r (p < 0.0001, p = 0.03, and p = 0.02, respectively). The heterozygote genotype combination GTba as compared to wild-type combination GGbb was significantly higher in HAPE-p (χ2 = 18.62, p = 0.00009; odds ratio, 7.20; 95% confidence interval, 2.82 to 18.38). The combination of four heterozygotes GTbaAGTC was overrepresented in HAPE-p (p = 0.04), whereas the wild-type genotype combination GGbbAATT was overrepresented in HAPE-r (p = 0.002). Furthermore, the GGbb combination correlated with significantly elevated NOx as compared to remaining combinations as a whole in both HAPE-r and HAPE-p (p = 0.01 and 0.004, respectively).
Reduced NOx and combination of heterozygotes associate with the susceptibility to HAPE. The study impels another step toward application of NOx as a diagnostic marker for HAPE. The NOS3 GTba and GTbaAGTC genotype combinations may find application as genetic markers for predicting the risk for HAPE.</description><identifier>ISSN: 0012-3692</identifier><identifier>EISSN: 1931-3543</identifier><identifier>DOI: 10.1378/chest.130.5.1511</identifier><identifier>PMID: 17099031</identifier><identifier>CODEN: CHETBF</identifier><language>eng</language><publisher>Northbrook, IL: Elsevier Inc</publisher><subject>Adult ; Altitude ; Biological and medical sciences ; Biomarkers - metabolism ; Blood vessels ; Cardiology. Vascular system ; Case-Control Studies ; Confidence intervals ; Cross-Sectional Studies ; DNA - genetics ; Edema ; Endothelium ; Gene Frequency - genetics ; Genes ; Genetic Predisposition to Disease - genetics ; Genotype ; Genotype & phenotype ; genotype combination ; Haplotypes ; Haplotypes - genetics ; Heterozygote ; high-altitude hypoxia ; high-altitude pulmonary edema ; Humans ; Hypoxia ; Hypoxia - metabolism ; Investigations ; Male ; Medical sciences ; Nitric oxide ; Nitric Oxide Synthase Type III - genetics ; Nitrogen ; Nitrogen Oxides - metabolism ; NOS3 polymorphisms ; Pneumology ; Polymorphism ; Polymorphism, Genetic ; Pulmonary Edema - diagnosis ; Pulmonary Edema - genetics ; Pulmonary Edema - metabolism ; Respiratory system : syndromes and miscellaneous diseases ; Risk Factors ; Sea level ; Tandem Repeat Sequences - genetics ; Variance analysis</subject><ispartof>Chest, 2006-11, Vol.130 (5), p.1511-1519</ispartof><rights>2006 The American College of Chest Physicians</rights><rights>2007 INIST-CNRS</rights><rights>Copyright American College of Chest Physicians Nov 2006</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c512t-e705beb5255fdd2f41d6c7631b1fbc43c3b0994ba05402ee445c5b3e6db80cb83</citedby><cites>FETCH-LOGICAL-c512t-e705beb5255fdd2f41d6c7631b1fbc43c3b0994ba05402ee445c5b3e6db80cb83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18299838$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17099031$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ahsan, Aarif</creatorcontrib><creatorcontrib>Mohd, Ghulam</creatorcontrib><creatorcontrib>Norboo, Tsering</creatorcontrib><creatorcontrib>Baig, Masroor A.</creatorcontrib><creatorcontrib>Pasha, M. A. Qadar</creatorcontrib><title>Heterozygotes of NOS3 Polymorphisms Contribute to Reduced Nitrogen Oxides in High-Altitude Pulmonary Edema</title><title>Chest</title><addtitle>Chest</addtitle><description>High-altitude pulmonary edema (HAPE), which develops on exertion under hypoxic conditions, aggravates due to endothelial dysfunction. Repeat events of the disorder suggests of genetic susceptibility. Endothelial nitric oxide synthase gene (NOS3), a regulator of vasodilation, has emerged as a strong candidate marker. In the present study, we investigated G894T, 27-base-pair 4b/4a (variable number of tandem repeat), −922A/G, and −786T/C polymorphisms of NOS3, individually or in combination, for an association with HAPE.
A cross-sectional case control study.
Blood samples of HAPE-resistant lowlanders (HAPE-r) were obtained at sea level, and blood samples of patients with HAPE (HAPE-p) were obtained at Sonam Norboo Memorial Hospital, Leh, at 3,500 m.
The study groups consisted of 60 HAPE-r inducted two to three times to altitudes > 3,600 m; and 72 HAPE-p, who had HAPE on their first visit to high altitude.
Nitrogen oxides (NOx) at 77.9 ± 28.6 μmol/L were significantly elevated in HAPE-r as compared to 42.39 ± 12.93 μmol/L in HAPE-p (p < 0.0001). Genotype distribution of G894T and 4b/4a polymorphisms was significantly different in the two groups (p = 0.001 and 0.009, respectively). Haplotype analysis revealed −922A/G and −786T/C polymorphisms in complete linkage disequilibrium. The wild-type haplotypes G-b (G894T, 4b/4a), G-A (G894T, −922A/G), and G-b-A (G894T, 4b/4a, −922A/G) were significantly overrepresented in HAPE-r (p < 0.0001, p = 0.03, and p = 0.02, respectively). The heterozygote genotype combination GTba as compared to wild-type combination GGbb was significantly higher in HAPE-p (χ2 = 18.62, p = 0.00009; odds ratio, 7.20; 95% confidence interval, 2.82 to 18.38). The combination of four heterozygotes GTbaAGTC was overrepresented in HAPE-p (p = 0.04), whereas the wild-type genotype combination GGbbAATT was overrepresented in HAPE-r (p = 0.002). Furthermore, the GGbb combination correlated with significantly elevated NOx as compared to remaining combinations as a whole in both HAPE-r and HAPE-p (p = 0.01 and 0.004, respectively).
Reduced NOx and combination of heterozygotes associate with the susceptibility to HAPE. The study impels another step toward application of NOx as a diagnostic marker for HAPE. The NOS3 GTba and GTbaAGTC genotype combinations may find application as genetic markers for predicting the risk for HAPE.</description><subject>Adult</subject><subject>Altitude</subject><subject>Biological and medical sciences</subject><subject>Biomarkers - metabolism</subject><subject>Blood vessels</subject><subject>Cardiology. Vascular system</subject><subject>Case-Control Studies</subject><subject>Confidence intervals</subject><subject>Cross-Sectional Studies</subject><subject>DNA - genetics</subject><subject>Edema</subject><subject>Endothelium</subject><subject>Gene Frequency - genetics</subject><subject>Genes</subject><subject>Genetic Predisposition to Disease - genetics</subject><subject>Genotype</subject><subject>Genotype & phenotype</subject><subject>genotype combination</subject><subject>Haplotypes</subject><subject>Haplotypes - genetics</subject><subject>Heterozygote</subject><subject>high-altitude hypoxia</subject><subject>high-altitude pulmonary edema</subject><subject>Humans</subject><subject>Hypoxia</subject><subject>Hypoxia - metabolism</subject><subject>Investigations</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Nitric oxide</subject><subject>Nitric Oxide Synthase Type III - genetics</subject><subject>Nitrogen</subject><subject>Nitrogen Oxides - metabolism</subject><subject>NOS3 polymorphisms</subject><subject>Pneumology</subject><subject>Polymorphism</subject><subject>Polymorphism, Genetic</subject><subject>Pulmonary Edema - diagnosis</subject><subject>Pulmonary Edema - genetics</subject><subject>Pulmonary Edema - metabolism</subject><subject>Respiratory system : syndromes and miscellaneous diseases</subject><subject>Risk Factors</subject><subject>Sea level</subject><subject>Tandem Repeat Sequences - genetics</subject><subject>Variance analysis</subject><issn>0012-3692</issn><issn>1931-3543</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kd1v0zAUxS0EYmXwzhOykMZbih3bacLbVG0UaVonPp6t2L5pXTlxsR1Y-evxaKSKSXuyLf3OvcfnIPSWkjlli_qj3kJM-UrmYk4Fpc_QjDaMFkxw9hzNCKFlwaqmPEOvYtyR_KZN9RKd0QVpGsLoDO1WkCD4P4eNTxCx7_Dt-hvDd94deh_2Wxv7iJd-SMGqMQFOHn8FM2ow-Nam4Dcw4PW9NVlrB7yym21x6ZJNowF8N7reD2044CsDffsavehaF-HNdJ6jH9dX35er4mb9-cvy8qbQgpapgAURCpQoheiMKTtOTaUXFaOKdkpzppnK5rlqieCkBOBcaKEYVEbVRKuanaMPx7n74H-OOSDZ26jBuXYAP0ZZ1ZRxVtIMvn8E7vwYhuxNloTwitd1kyFyhHTwMQbo5D7YPn9KUiIfSpD_SshXIoV8KCFL3k1zR9WDOQmm1DNwMQFt1K3rQjtoG09cXTZNzerT7m3O9bcNIGPfOpfHsuPWye9_uz8dJZAT_mUhyKgtDLmvLNdJGm-fNv4XjGu1_w</recordid><startdate>20061101</startdate><enddate>20061101</enddate><creator>Ahsan, Aarif</creator><creator>Mohd, Ghulam</creator><creator>Norboo, Tsering</creator><creator>Baig, Masroor A.</creator><creator>Pasha, M. A. Qadar</creator><general>Elsevier Inc</general><general>American College of Chest Physicians</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20061101</creationdate><title>Heterozygotes of NOS3 Polymorphisms Contribute to Reduced Nitrogen Oxides in High-Altitude Pulmonary Edema</title><author>Ahsan, Aarif ; Mohd, Ghulam ; Norboo, Tsering ; Baig, Masroor A. ; Pasha, M. A. Qadar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c512t-e705beb5255fdd2f41d6c7631b1fbc43c3b0994ba05402ee445c5b3e6db80cb83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adult</topic><topic>Altitude</topic><topic>Biological and medical sciences</topic><topic>Biomarkers - metabolism</topic><topic>Blood vessels</topic><topic>Cardiology. Vascular system</topic><topic>Case-Control Studies</topic><topic>Confidence intervals</topic><topic>Cross-Sectional Studies</topic><topic>DNA - genetics</topic><topic>Edema</topic><topic>Endothelium</topic><topic>Gene Frequency - genetics</topic><topic>Genes</topic><topic>Genetic Predisposition to Disease - genetics</topic><topic>Genotype</topic><topic>Genotype & phenotype</topic><topic>genotype combination</topic><topic>Haplotypes</topic><topic>Haplotypes - genetics</topic><topic>Heterozygote</topic><topic>high-altitude hypoxia</topic><topic>high-altitude pulmonary edema</topic><topic>Humans</topic><topic>Hypoxia</topic><topic>Hypoxia - metabolism</topic><topic>Investigations</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Nitric oxide</topic><topic>Nitric Oxide Synthase Type III - genetics</topic><topic>Nitrogen</topic><topic>Nitrogen Oxides - metabolism</topic><topic>NOS3 polymorphisms</topic><topic>Pneumology</topic><topic>Polymorphism</topic><topic>Polymorphism, Genetic</topic><topic>Pulmonary Edema - diagnosis</topic><topic>Pulmonary Edema - genetics</topic><topic>Pulmonary Edema - metabolism</topic><topic>Respiratory system : syndromes and miscellaneous diseases</topic><topic>Risk Factors</topic><topic>Sea level</topic><topic>Tandem Repeat Sequences - genetics</topic><topic>Variance analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ahsan, Aarif</creatorcontrib><creatorcontrib>Mohd, Ghulam</creatorcontrib><creatorcontrib>Norboo, Tsering</creatorcontrib><creatorcontrib>Baig, Masroor A.</creatorcontrib><creatorcontrib>Pasha, M. A. Qadar</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Chest</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ahsan, Aarif</au><au>Mohd, Ghulam</au><au>Norboo, Tsering</au><au>Baig, Masroor A.</au><au>Pasha, M. A. Qadar</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Heterozygotes of NOS3 Polymorphisms Contribute to Reduced Nitrogen Oxides in High-Altitude Pulmonary Edema</atitle><jtitle>Chest</jtitle><addtitle>Chest</addtitle><date>2006-11-01</date><risdate>2006</risdate><volume>130</volume><issue>5</issue><spage>1511</spage><epage>1519</epage><pages>1511-1519</pages><issn>0012-3692</issn><eissn>1931-3543</eissn><coden>CHETBF</coden><abstract>High-altitude pulmonary edema (HAPE), which develops on exertion under hypoxic conditions, aggravates due to endothelial dysfunction. Repeat events of the disorder suggests of genetic susceptibility. Endothelial nitric oxide synthase gene (NOS3), a regulator of vasodilation, has emerged as a strong candidate marker. In the present study, we investigated G894T, 27-base-pair 4b/4a (variable number of tandem repeat), −922A/G, and −786T/C polymorphisms of NOS3, individually or in combination, for an association with HAPE.
A cross-sectional case control study.
Blood samples of HAPE-resistant lowlanders (HAPE-r) were obtained at sea level, and blood samples of patients with HAPE (HAPE-p) were obtained at Sonam Norboo Memorial Hospital, Leh, at 3,500 m.
The study groups consisted of 60 HAPE-r inducted two to three times to altitudes > 3,600 m; and 72 HAPE-p, who had HAPE on their first visit to high altitude.
Nitrogen oxides (NOx) at 77.9 ± 28.6 μmol/L were significantly elevated in HAPE-r as compared to 42.39 ± 12.93 μmol/L in HAPE-p (p < 0.0001). Genotype distribution of G894T and 4b/4a polymorphisms was significantly different in the two groups (p = 0.001 and 0.009, respectively). Haplotype analysis revealed −922A/G and −786T/C polymorphisms in complete linkage disequilibrium. The wild-type haplotypes G-b (G894T, 4b/4a), G-A (G894T, −922A/G), and G-b-A (G894T, 4b/4a, −922A/G) were significantly overrepresented in HAPE-r (p < 0.0001, p = 0.03, and p = 0.02, respectively). The heterozygote genotype combination GTba as compared to wild-type combination GGbb was significantly higher in HAPE-p (χ2 = 18.62, p = 0.00009; odds ratio, 7.20; 95% confidence interval, 2.82 to 18.38). The combination of four heterozygotes GTbaAGTC was overrepresented in HAPE-p (p = 0.04), whereas the wild-type genotype combination GGbbAATT was overrepresented in HAPE-r (p = 0.002). Furthermore, the GGbb combination correlated with significantly elevated NOx as compared to remaining combinations as a whole in both HAPE-r and HAPE-p (p = 0.01 and 0.004, respectively).
Reduced NOx and combination of heterozygotes associate with the susceptibility to HAPE. The study impels another step toward application of NOx as a diagnostic marker for HAPE. The NOS3 GTba and GTbaAGTC genotype combinations may find application as genetic markers for predicting the risk for HAPE.</abstract><cop>Northbrook, IL</cop><pub>Elsevier Inc</pub><pmid>17099031</pmid><doi>10.1378/chest.130.5.1511</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0012-3692 |
ispartof | Chest, 2006-11, Vol.130 (5), p.1511-1519 |
issn | 0012-3692 1931-3543 |
language | eng |
recordid | cdi_proquest_miscellaneous_68134321 |
source | MEDLINE; Alma/SFX Local Collection |
subjects | Adult Altitude Biological and medical sciences Biomarkers - metabolism Blood vessels Cardiology. Vascular system Case-Control Studies Confidence intervals Cross-Sectional Studies DNA - genetics Edema Endothelium Gene Frequency - genetics Genes Genetic Predisposition to Disease - genetics Genotype Genotype & phenotype genotype combination Haplotypes Haplotypes - genetics Heterozygote high-altitude hypoxia high-altitude pulmonary edema Humans Hypoxia Hypoxia - metabolism Investigations Male Medical sciences Nitric oxide Nitric Oxide Synthase Type III - genetics Nitrogen Nitrogen Oxides - metabolism NOS3 polymorphisms Pneumology Polymorphism Polymorphism, Genetic Pulmonary Edema - diagnosis Pulmonary Edema - genetics Pulmonary Edema - metabolism Respiratory system : syndromes and miscellaneous diseases Risk Factors Sea level Tandem Repeat Sequences - genetics Variance analysis |
title | Heterozygotes of NOS3 Polymorphisms Contribute to Reduced Nitrogen Oxides in High-Altitude Pulmonary Edema |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T07%3A09%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Heterozygotes%20of%20NOS3%20Polymorphisms%20Contribute%20to%20Reduced%20Nitrogen%20Oxides%20in%20High-Altitude%20Pulmonary%20Edema&rft.jtitle=Chest&rft.au=Ahsan,%20Aarif&rft.date=2006-11-01&rft.volume=130&rft.issue=5&rft.spage=1511&rft.epage=1519&rft.pages=1511-1519&rft.issn=0012-3692&rft.eissn=1931-3543&rft.coden=CHETBF&rft_id=info:doi/10.1378/chest.130.5.1511&rft_dat=%3Cproquest_cross%3E1174702201%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=200464889&rft_id=info:pmid/17099031&rft_els_id=S001236921537330X&rfr_iscdi=true |